ATE108188T1 - Laminin bindende peptidfragmente. - Google Patents

Laminin bindende peptidfragmente.

Info

Publication number
ATE108188T1
ATE108188T1 AT87907048T AT87907048T ATE108188T1 AT E108188 T1 ATE108188 T1 AT E108188T1 AT 87907048 T AT87907048 T AT 87907048T AT 87907048 T AT87907048 T AT 87907048T AT E108188 T1 ATE108188 T1 AT E108188T1
Authority
AT
Austria
Prior art keywords
binding peptide
peptide fragments
laminin binding
laminin
probe
Prior art date
Application number
AT87907048T
Other languages
English (en)
Inventor
Mark E Sobel
Lance A Liotta
Ulla M Wewer
Michael C Jaye
William N Drohan
Original Assignee
Us Commerce
Rorer Int Holdings
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Commerce, Rorer Int Holdings filed Critical Us Commerce
Application granted granted Critical
Publication of ATE108188T1 publication Critical patent/ATE108188T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/811Test for named disease, body condition or organ function
    • Y10S436/813Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT87907048T 1986-09-26 1987-09-23 Laminin bindende peptidfragmente. ATE108188T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/911,863 US4861710A (en) 1986-09-26 1986-09-26 Recombinant DNA clone encoding laminin receptor

Publications (1)

Publication Number Publication Date
ATE108188T1 true ATE108188T1 (de) 1994-07-15

Family

ID=25431000

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87907048T ATE108188T1 (de) 1986-09-26 1987-09-23 Laminin bindende peptidfragmente.

Country Status (7)

Country Link
US (1) US4861710A (de)
EP (1) EP0324788B1 (de)
JP (3) JP2533595B2 (de)
AT (1) ATE108188T1 (de)
CA (1) CA1305678C (de)
DE (1) DE3750180T2 (de)
WO (1) WO1988002407A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0431065A1 (de) * 1988-08-31 1991-06-12 Dana Farber Cancer Institute Vollständige cdns, kodierend für ein menschliches lamininbindendes protein
US5175251A (en) * 1989-05-04 1992-12-29 Sri International Antimetastatic peptides with laminin activity
CA2040099A1 (en) * 1990-05-01 1991-11-02 Mariano Barbacid Tyrosine kinase negative trkb
AU5544500A (en) * 1999-06-15 2001-01-02 Astrazeneca Ab Livin; inhibitor-of-apoptosis protein-3 (iap-3)
US20040092724A1 (en) * 2000-07-28 2004-05-13 Mcguckin Michael Andrew Mucin
US20030118585A1 (en) * 2001-10-17 2003-06-26 Agy Therapeutics Use of protein biomolecular targets in the treatment and visualization of brain tumors
CA2502479A1 (en) * 2004-12-01 2006-06-01 Procyon Biopharma Inc. Laminin receptor binding molecule
EP2330122A1 (de) 2009-12-02 2011-06-08 Asklepios Kliniken Hamburg Gmbh OFA/iLRP-abgeleitetes modifiziertes Peptid
GB201700529D0 (en) * 2017-01-12 2017-03-01 Rogers April Laminin receptor peptide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4628027A (en) * 1982-05-19 1986-12-09 Molecular Engineering Associates, Ltd. Vitro diagnostic methods using monoclonal antibodies against connective tissue proteins
US4589881A (en) * 1982-08-04 1986-05-20 La Jolla Cancer Research Foundation Polypeptide
US4699877A (en) * 1982-11-04 1987-10-13 The Regents Of The University Of California Methods and compositions for detecting human tumors
US4565789A (en) * 1983-04-04 1986-01-21 The United States Of America As Represented By The Department Of Health And Human Services Cell matrix receptor system and use in cancer diagnosis and management

Also Published As

Publication number Publication date
EP0324788B1 (de) 1994-07-06
DE3750180D1 (de) 1994-08-11
JP2825780B2 (ja) 1998-11-18
EP0324788A4 (de) 1990-03-28
EP0324788A1 (de) 1989-07-26
JP2533595B2 (ja) 1996-09-11
JPH0880200A (ja) 1996-03-26
WO1988002407A1 (en) 1988-04-07
JPH02500637A (ja) 1990-03-08
DE3750180T2 (de) 1994-11-03
US4861710A (en) 1989-08-29
JPH06107691A (ja) 1994-04-19
CA1305678C (en) 1992-07-28

Similar Documents

Publication Publication Date Title
BR9916207A (pt) Composições e métodos para terapia e diagnósticode câncer ovariano
HUP0302532A2 (hu) Petefészekrák terápiájában és diagnosztizálásában alkalmazható készítmények és eljárások
DK1442058T3 (da) Peptider der er effektive til behandling af tumorer og andre tilstande der kræver fjernelse eller destruktion af celler
DK161015C (da) Blanding til anvendelse ved ekstern paavisning og lokalisering af en blodprop
AR006250A1 (es) Compuestos y metodos para la inmunoterapia e inmunodiagnostico del cancer prostatico
IT8321287A0 (it) Procedimento per l'ottenimento della endotossina, disintossicata, raffinata, la endotossina ottenuta e l'impiego terapeutico di essa.
BR0008161A (pt) Uso de uma composição terapêutica para tratamento de uma célula tumoral, composição terapêutica, e kit para tratamento de uma célula tumoral
TR200103560T2 (tr) Göğüs kanserinin teşhis ve tedavisi için bileşimler ve bunların kullanımı
RU2001104349A (ru) Композиции и способы для терапии и диагностики рака предстательной железы
DE69737788D1 (de) Reagenzien und methoden zum nachweis von erkrankungen der brust
TR200001646T2 (tr) Bir salgılanmış meme kanseri proteini olan mamaglobin.
ES534098A0 (es) Procedimiento para la obtencion de eglinas b o c modificadas
BR9808509A (pt) Composições e métodos para o tratamento e diagnóstico do câncer de mama
ATE108188T1 (de) Laminin bindende peptidfragmente.
IT8423624A0 (it) Procedimento di trattamento termico di cariche idrocarburiche in presenza di additivi che diminuiscono la formazione di coke.
ES2072251T3 (es) Composiciones y metodos para la sintesis y ensayo de enquefalinasa.
DE68921979D1 (de) Antikörper für die antilymphozyten-antikörpertherapie.
DE69735020D1 (de) Verfahren zur Diagnose von Prostatakrebs
MXPA03005436A (es) Polinucleotidos novedosos que codifican fosfastasas humanas.
DE69021742D1 (de) Verfahren zum Nachweis von kleinzelligem Carzinom und die Verwendung von Sequenzen, die Acylpeptid-Hydrolase codieren, für diesen zweck.
ES8704082A1 (es) Procedimiento para preparar un agente terapeutico a base de celulas tumorales humanas y eventualmente, neuraminidasa.
HUP9800744A2 (hu) Fas-antigén elleni antitestek
DK0495910T3 (da) Fremstilling og anvendelse af humant nm23-H2-protein og derimod rettede antistoffer
DE69942637D1 (de) Zusammensetzungen und verfahren für die therapie und diagnose von ovariumkrebs
EP1012338A4 (de) Ein tumorsuppressor namens ts10q23.3